Tempus AI (TEM) Stock Could Be Below Fair Value On Its 19% Jump

Simply Wall St.

Jul 03

Tempus AI stock has climbed 18.6% over the past week, yet the valuation checks send a mixed message, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to meaningful upside while ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2648633802"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2648633802\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2648633802?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","is_english":true,"pubTime":"2026-07-03 03:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2648633802","market":"nz","top_or_hot":-1,"title":"Tempus AI (TEM) Stock Could Be Below Fair Value On Its 19% Jump","media":"Simply Wall St.","content":"<div>\n<p>Tempus AI stock has climbed 18.6% over the past week, yet the valuation checks send a mixed message, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to meaningful upside while ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/tempus-ai-tem-stock-could-be-below-fair-value-on-its-19-jump\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tempus AI (TEM) Stock Could Be Below Fair Value On Its 19% Jump</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTempus AI (TEM) Stock Could Be Below Fair Value On Its 19% Jump\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-07-03 03:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/tempus-ai-tem-stock-could-be-below-fair-value-on-its-19-jump><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tempus AI stock has climbed 18.6% over the past week, yet the valuation checks send a mixed message, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to meaningful upside while ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/tempus-ai-tem-stock-could-be-below-fair-value-on-its-19-jump\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TEMT","symbol_name":"2倍做多TEM ETF-Tradr","start_time":0,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/tempus-ai-tem-stock-could-be-below-fair-value-on-its-19-jump","article_id":"2648633802","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/tempus-ai-tem-stock-could-be-below-fair-value-on-its-19-jump","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2648633802","pubTimestamp":1783021070,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Tempus AI stock has climbed 18.6% over the past week, yet the valuation checks send a mixed message, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to meaningful upside while the broader scorecard still leans expensive.\n\nThe 18.6% gain in the past week signals renewed enthusiasm around Tempus AI, putting more pressure on the valuation to justify the move.\nStrong revenue momentum and new partnerships in data driven cancer research can support expectations for future cash...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"TEMT":"2倍做多TEM ETF-Tradr","BK4613":"AI应用软件","LU1861558580.USD":"日兴方舟颠覆性创新基金B","BK4121":"生命科学工具和服务","LU1861559042.SGD":"日兴方舟颠覆性创新基金B SGD","BK4611":"AI医疗","TEM":"Tempus AI"},"translate_title":"Tempus AI(TEM)股价上涨19%，可能低于公允价值","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TEM":1.98,"TEMT":0.6},"content_text":"Tempus AI stock has climbed 18.6% over the past week, yet the valuation checks send a mixed message, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to meaningful upside while the broader scorecard still leans expensive.  The 18.6% gain in the past week signals renewed enthusiasm around Tempus AI, putting more pressure on the valuation to justify the move. Strong revenue momentum and new partnerships in data driven cancer research can support expectations for future cash flows, while insider share sales and the path to sustained profitability may keep some investors cautious. With a valuation score of 2 out of 6, Tempus AI does not screen as a clear bargain on the broader checks even though the DCF suggests it could be undervalued by about 36.8%.  The issue now is whether Tempus AI's current share price around US$61.60 still offers enough margin to align with that intrinsic value estimate. Find out why Tempus AI's 4.1% return over the last year is lagging behind its peers. AdvertisementIs Tempus AI Still Cheap on Cash Flow? The Discounted Cash Flow (DCF) model values Tempus AI by projecting its future cash generation and discounting it back to today. For Tempus AI, the latest twelve month free cash flow is a loss of $225.6 million. The model used here assumes recovering, growing cash flows over the next decade as the business scales. Based on those projections, the DCF points to an estimated intrinsic value of about $97.51 per share, compared with the current share price around $61.60. This implies the stock screens roughly 36.8% below that cash flow based estimate. The recent research collaboration on rare cancer and growing attention on Tempus AI’s data and AI platform are among the reasons some investors may be willing to look past current losses and focus on the longer term cash flow potential. On the cash flow math used here, Tempus AI stock currently appears undervalued relative to its DCF based intrinsic value estimate. Our Discounted Cash Flow (DCF) analysis suggests Tempus AI is undervalued by 36.8%. Track this in your watchlist or portfolio, or discover 41 more high quality undervalued stocks. TEM Discounted Cash Flow as at Jul 2026 Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Tempus AI. Does Tempus AI Look Fairly Valued on Sales? P/S is a useful cross check for Tempus AI because the company is still loss making, so earnings based multiples like P/E do not yet give a clear signal. On this metric, Tempus AI trades on a P/S of about 8.1x, which is above both the Life Sciences industry average of 4.1x and the peer group average of 4.7x. The fair P/S ratio for Tempus AI, based on its growth profile, margins, size and risk, is estimated at 7.9x, only slightly below the current level. That narrow gap suggests the stock is not priced at a sharp premium or discount on sales, even after recent news around new research collaborations and management’s focus on improving profitability. On the P/S yardstick, Tempus AI stock appears roughly fairly valued relative to what the model indicates could be a reasonable multiple for its fundamentals. NasdaqGS:TEM P/S Ratio as at Jul 2026 See what the numbers say about this price — find out in our valuation breakdown. The Tempus AI Narrative: What Would Justify Today's Price? Simply Wall St Narratives for Tempus AI build on this valuation puzzle by outlining which paths for Tempus AI's growth, margins and earnings would need to occur for the stock to be worth meaningfully more or less than its current price. These narratives are available on the company’s Community page. Each narrative links its number to a clear view of how Tempus AI's growth, profitability and risks could evolve, giving you something concrete to track as new information emerges. Tempus AI inspires sharply different views in the community, with some focusing on the depth of its data platform and others on execution risk and future economics. Bull case: 7% undervalued \"Every new test and partnership adds more data, making its AI models more valuable and creating opportunities to cross-sell additional products and services...\" Read the full Bull Case to see why Tempus AI could be undervalued Bear case: 6% overvalued \"Large technology and healthcare players are pushing into AI driven clinical data and diagnostics, and if they secure comparable datasets or tighter distribution with providers, Tempus AI's current advantage in proprietary data and hospital connectivity could erode over time...\" Read the full Bear Case to see why Tempus AI could be overvalued Do you think there's more to the story for Tempus AI? Head over to our Community to see what others are saying! The Bottom Line For Tempus AI, the Discounted Cash Flow (DCF) work points to meaningful upside relative to the current share price, while the P/S view suggests the stock is priced roughly in line with what the model treats as a reasonable sales multiple. That split, alongside a weaker overall value score, highlights how much the intrinsic value case depends on future cash flow improving from today’s losses. The core question from here is whether Tempus AI can convert its data and partnerships into a path to sustained, attractive profitability rather than the current discount reflecting execution and competitive risks.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.Valuation is complex, but we're here to simplify it.Discover if Tempus AI might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}